Clinical Trial

Safety and Food Effect on Single-Dose Bioavailability of F-02-2-Na in Healthy Adult Subjects

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated July 30, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The study is to evaluate the impact of food on the pharmacokinetics of F-02-2-Na in healthy adult subjects by observing the changes in the drug's pharmacokinetic profile-particularly in its absorption process-before and after food intake.
Protocol Amendment History 3 changes
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-07-31
notable Primary completion pushed: 2026-04-01 -> 2026-08-01 2026-06-18
minor Completion pushed: 2026-06-01 -> 2026-09-01 2026-06-18
Trial Details
NCT Number NCT07346027
Lead Sponsor Guangdong Hengqin Novagains Biopharmaceutical Co., Ltd.
Collaborators: Xiangbei Welman Pharmaceutical Co., Ltd, Guangzhou Xin-Chuangyi Biopharmaceutical Co., Ltd.
Conditions Hyperuricemia With or Without Gout
Enrollment 12 participants
Start Date 2026-06-25
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-30